18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease:a preliminary study
NUCLEAR CHEMISTRY, RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE|更新时间:2024-10-25
|
18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease:a preliminary study
封面论文
“18F-FMM PET/CT brain imaging can intuitively reflect the cognitive level of middle-aged and elderly people, and has practical value in the diagnosis of MCI and AD.”
LEI Zhe, female, born in 1996, graduated from Zhengzhou University in 2019, master student, focusing on diagnosis and treatment related to nuclear medicine
LOU Jingjing, E-mail: 1436150464@qq.com
LIU Xingdang, E-mail: xingdliu@fudan.edu.cn
基金信息:
Shanghai "Science and Technology Innovation Action Plan" Major Research Program in Clinical Medicine Field(17411950102);National Key Research and Development Plan Digital Diagnosis and Treatment Equipment Research and Development Project(2017YFC0113300);Pudong Hospital, the Pudong New Area Clinical Characteristic Discipline Project(PWYts2021-01);Fudan University, College Project(YJYJRC202108/YJYJRC202101/Zdzk2020-14)
LEI Zhe,WU Han,OU Yinghui,et al.18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease:a preliminary study[J].NUCLEAR TECHNIQUES,2022,45(07):070301-070301.
LEI Zhe,WU Han,OU Yinghui,et al.18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease:a preliminary study[J].NUCLEAR TECHNIQUES,2022,45(07):070301-070301. DOI: 10.11889/j.0253-3219.2022.hjs.45.070301.
18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease:a preliminary study封面论文